Skip to main content
Clinical Trials/NCT04901039
NCT04901039
Terminated
Not Applicable

Strategies for Assessment of Fluid Overload in Acute Decompensated Heart Failure

Region Skane2 sites in 1 country21 target enrollmentApril 14, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Heart Failure
Sponsor
Region Skane
Enrollment
21
Locations
2
Primary Endpoint
Rehospitalization/mortality
Status
Terminated
Last Updated
2 years ago

Overview

Brief Summary

Heart failure (HF) is the endstage of all heart disease, characterized by inability of either the left or right heart or both to maintain sufficient output of blood for the demands of the body at normal filling pressures. Patients with HF are often admitted to hospital with decompensation and treated with diuretics. Residual congestion at discharge is associated with increased risk of early rehospitalization and adverse outcomes. However, determination of residual decompensation is complicated and a large number of patients admitted with decompensated heart failure are likely discharged before optimal decongestion has been achieved. Lung ultrasound (LUS) is a promising method to determine residual decompensation with the evaluation of B-lines. In this study our primary aim is to evaluate if LUS together with echocardiographic evaluation of filling pressure according to the European Society of Cardiology (ESC) algorithm performs better than clinical assessment to determine fluid status and risk of early rehospitalization in patients hospitalized for AHF.

Registry
clinicaltrials.gov
Start Date
April 14, 2022
End Date
June 1, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Acute coronary syndrome, cardiogenic chock

Outcomes

Primary Outcomes

Rehospitalization/mortality

Time Frame: 2021-2023

Rehospitalization or death within 30 days due to decompensated heart failure

Study Sites (2)

Loading locations...

Similar Trials